1. Data & Insights

From Data Gaps to Revenue Gains: Harnessing the Power of Comprehensive Data to Drive GTN

Today’s guest post comes from Thomas Luby, Sr. Vice President, Business Development at PHIL.

Thomas discusses the challenges brands face as they manage gross-to-net (GTN) performance while simultaneously enhancing patient access and adherence. He lists the key performance indicators that can help brands improve GTN.

To learn more, watch PHIL’s free on-demand webinar: Four Patient Access Barriers to Address for High-Impact Programs.

Read on for Thomas’s insights.

Read more »

       
View Original Article
https://www.drugchannels.net/
Do you like Drug Channels's articles? Follow on social!